OCT 21, 2021 5:00 AM PDT

Dementia Diagnostic Looks for 'Hungry' Immune Cells in the Brain

WRITTEN BY: Tara Fernandez

Experts have long known that the immune cells in our brains called microglia are important for preserving neural tissue health. In a new study, researchers have found a connection between how these cells consume glucose and the onset of neurodegenerative disease.

Microglia, also known as macrophages of the central nervous system (CNS), are immune cells found peppering the brain and spinal cord; they act as a first-line defense against pathogens and tissue damage.

In findings reported in Science Translational Medicine, a team of German scientists described using a method called positron emission tomography (PET) to image glucose molecules labeled with a radioactive tracer in the brain.

Positron emission tomography (PET) is an imaging technique used for functional and molecular biological studies and diagnostic purposes. It creates images of organs and tissues inside the body by using a small amount of a radioactive substance.

The brain's energy consumption also fluctuates as a result of age and neurodegenerative disease. Therefore, mapping glucose hotspots and energy demands in neural tissue holds particular promise as a diagnostic tool.

Interestingly, the team found that in a cohort of 30 patients with dementia, a strong signal was emitted predominantly from the brain's microglial cells. The team also found that microglial metabolism closely correlated between different stages of neurodegeneration, both in terms of the amount of glucose used by these cells and how strongly they were labeled with radioactive tracers.

In 2017, an estimated 46 million people around the globe were living with dementia, a number expected to double by 2030. The incurable condition kills about 30 percent of patients within five years after diagnosis and 50 percent within ten years from onset. 

A growing body of research points to the crucial and protective role microglia play against conditions such as Alzheimer's. Therefore, watching how these cells are behaving--particularly in high-risk patients or those being treated for dementia--may help doctors better address the needs of these vulnerable patients.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 15, 2021
Microbiology
Lyme Disease Linked to Significantly Increased Suicide Risk
AUG 15, 2021
Lyme Disease Linked to Significantly Increased Suicide Risk
While about 30,000 cases of Lyme disease are reported to the CDC every year, the disease has been estimated to cause abu ...
AUG 29, 2021
Cancer
Blood Test over 90% Accurate in Detecting Lung Cancer
AUG 29, 2021
Blood Test over 90% Accurate in Detecting Lung Cancer
An AI-powered blood test was able to correctly detect the presence of lung cancer over 90% of the time in patient sample ...
OCT 11, 2021
Cancer
Different Cancer Types Metastasize to Specific Regions of the Brain
OCT 11, 2021
Different Cancer Types Metastasize to Specific Regions of the Brain
Metastatic cancer occurs when cancer spreads from its original site of origin to a distant location in the body. Wh ...
OCT 14, 2021
Clinical & Molecular DX
Weighing Cancer Cells Helps Predict Treatment Outcomes
OCT 14, 2021
Weighing Cancer Cells Helps Predict Treatment Outcomes
Not all cancer patients respond to oncology treatments in the same way. Some might show signs of improvement as the ther ...
OCT 28, 2021
Clinical & Molecular DX
Asthma Diagnostic Detects Leaky Airways
OCT 28, 2021
Asthma Diagnostic Detects Leaky Airways
Both asthma and chronic obstructive pulmonary disease (COPD) are airway disorders associated with elevated, uncontrolled ...
NOV 08, 2021
Clinical & Molecular DX
Sample Prep Possibilities: How to Gauge Your "Good Enough"
NOV 08, 2021
Sample Prep Possibilities: How to Gauge Your "Good Enough"
As scientists, we can be very uncomfortable with the concept of “good enough”. It feels contrary to everythi ...
Loading Comments...